Listening to silence and understanding nonsense: exonic mutations that affect splicing
暂无分享,去创建一个
[1] F. Welch,et al. Causes and Consequences , 2017, Nature.
[2] Causes and consequences , 2021 .
[3] H. Bartsch,et al. International Agency for Research on Cancer. , 1969, WHO chronicle.
[4] D. Mccormick. Sequence the Human Genome , 1986, Bio/Technology.
[5] L. Hood,et al. The molecular genetics of the T-cell antigen receptor and T-cell antigen recognition. , 1986, Annual review of immunology.
[6] D. Etchison,et al. Monoclonal antibody-aided characterization of cellular p220 in uninfected and poliovirus-infected HeLa cells: subcellular distribution and identification of conformers , 1987, Journal of virology.
[7] L. Kunkel,et al. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. , 1989, American journal of human genetics.
[8] S. Ho,et al. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. , 1989, Gene.
[9] L. Chasin,et al. Nonsense mutations in the dihydrofolate reductase gene affect RNA processing , 1989, Molecular and cellular biology.
[10] S. Berget,et al. Exon definition may facilitate splice site selection in RNAs with multiple exons. , 1990, Molecular and cellular biology.
[11] L. Gold,et al. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.
[12] Robert M. Horton,et al. Gene splicing by overlap extension. , 1990 .
[13] J. Chelly,et al. A "G" to "A" mutation at position -1 of a 5' splice site in a late infantile form of Tay-Sachs disease. , 1990, The Journal of biological chemistry.
[14] S. Tsuji,et al. A novel exon mutation in the human beta-hexosaminidase beta subunit gene affects 3' splice site selection. , 1992, The Journal of biological chemistry.
[15] C. Burd,et al. hnRNP proteins and the biogenesis of mRNA. , 1993, Annual review of biochemistry.
[16] Y. Shimura,et al. The role of exon sequences in splice site selection. , 1993, Genes & development.
[17] E. Birney,et al. Analysis of the RNA-recognition motif and RS and RGG domains: conservation in metazoan pre-mRNA splicing factors. , 1993, Nucleic acids research.
[18] L. Kunkel,et al. The structural and functional diversity of dystrophin , 1993, Nature Genetics.
[19] David Valle,et al. The skipping of constitutive exons in vivo induced by nonsense mutations , 1993, Science.
[20] C. Mathew,et al. A nonsense mutation and exon skipping in the Fanconi anaemia group C gene. , 1993, Human molecular genetics.
[21] SR proteins promote the first specific recognition of Pre-mRNA and are present together with the U1 small nuclear ribonucleoprotein particle in a general splicing enhancer complex. , 1994, Molecular and cellular biology.
[22] S. Packman,et al. Diverse mutations in patients with Menkes disease often lead to exon skipping. , 1994, American journal of human genetics.
[23] G. Casari,et al. A novel bipartite splicing enhancer modulates the differential processing of the human fibronectin EDA exon. , 1994, Nucleic acids research.
[24] D. Rodriguez,et al. Aberrant Splicing of Exon 6 in the Pyruvate Denydrogenase-Elα mRNA Linked to a Silent Mutation in a Large Family with Leigh's Encephalomyelopathy , 1994, Pediatric Research.
[25] Koji Kariya-city Aichi-pref. Tanaka,et al. Polypurine sequences within a downstream exon function as a splicing enhancer , 1994, Molecular and cellular biology.
[26] H. Dietz,et al. Maintenance of an open reading frame as an additional level of scrutiny during splice site selection , 1994, Nature Genetics.
[27] B. Amendt,et al. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors , 1995, Molecular and cellular biology.
[28] L. Maquat. When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells. , 1995, RNA.
[29] R Kole,et al. Selection of novel exon recognition elements from a pool of random sequences , 1995, Molecular and cellular biology.
[30] J. Manley,et al. The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities. , 1995, The EMBO journal.
[31] J. Weissenbach,et al. Identification and characterization of a spinal muscular atrophy-determining gene , 1995, Cell.
[32] A. Federico,et al. Mutations in the X-linked E1 alpha subunit of pyruvate dehydrogenase: exon skipping, insertion of duplicate sequence, and missense mutations leading to the deficiency of the pyruvate dehydrogenase complex. , 1995, American journal of human genetics.
[33] N. Sonenberg,et al. Translational control of gene expression , 2000 .
[34] A. Zahler,et al. A subset of SR proteins activates splicing of the cardiac troponin T alternative exon by direct interactions with an exonic enhancer , 1995, Molecular and cellular biology.
[35] A. Staffa,et al. Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1 , 1995, Molecular and cellular biology.
[36] X. Wang. Molecular characterization of a novel defect occurring de novo associated with erythropoietic protoporphyria. , 1996, Biochimica et biophysica acta.
[37] H. Dietz,et al. Glanzmann thrombasthenia. Cooperation between sequence variants in cis during splice site selection. , 1996, The Journal of clinical investigation.
[38] T. Maniatis,et al. The splicing factor U2AF35 mediates critical protein-protein interactions in constitutive and enhancer-dependent splicing. , 1996, Genes & development.
[39] B. Chabot. Directing alternative splicing: cast and scenarios. , 1996, Trends in genetics : TIG.
[40] M. Kohonen-Corish,et al. RNA-based mutation screening in hereditary nonpolyposis colorectal cancer. , 1996, American journal of human genetics.
[41] R. Hardy,et al. Frequent aberrant immunoglobulin gene rearrangements in pro-B cells revealed by a bcl-xL transgene. , 1996, Immunity.
[42] P. Harrison,et al. Acute intermittent porphyria caused by defective splicing of porphobilinogen deaminase RNA: a synonymous codon mutation at -22 bp from the 5' splice site causes skipping of exon 3. , 1996, Journal of medical genetics.
[43] J. Manley,et al. Sequence-specific RNA binding by an SR protein requires RS domain phosphorylation: creation of an SRp40-specific splicing enhancer. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[44] T. Cooper,et al. Identification of a new class of exonic splicing enhancers by in vivo selection , 1997, Molecular and cellular biology.
[45] I. Tsukimoto,et al. Frame shift mutation, exon skipping, and a two-codon deletion caused by splice site mutations account for pyruvate kinase deficiency. , 1997, Blood.
[46] M. Corey,et al. A missense cystic fibrosis transmembrane conductance regulator mutation with variable phenotype. , 1997, Pediatrics.
[47] Y. Takeshima,et al. Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy. , 1997, The Journal of clinical investigation.
[48] A. Aguzzi,et al. Adenosine deaminase deficiency in adults. , 1997, Blood.
[49] C. R. Valentine,et al. The association of nonsense mutation with exon-skipping in hprt mRNA of Chinese hamster ovary cells results from an artifact of RT-PCR. , 1997, RNA.
[50] U. Francke,et al. Silent mutation induces exon skipping of fibrillin-1 gene in Marfan syndrome , 1997, Nature Genetics.
[51] T. Cooper,et al. The regulation of splice-site selection, and its role in human disease. , 1997, American journal of human genetics.
[52] C. R. Valentine,et al. The association of nonsense codons with exon skipping. , 1998, Mutation research.
[53] A. Schambach,et al. Different missense mutations in histidine‐108 of lysosomal acid lipase cause cholesteryl ester storage disease in unrelated compound heterozygous and hemizygous individuals , 1998, Human mutation.
[54] A. J. Lopez,et al. Alternative splicing of pre-mRNA: developmental consequences and mechanisms of regulation. , 1998, Annual review of genetics.
[55] A. Krainer,et al. Identification of Functional Exonic Splicing Enhancer Motifs Recognized by Individual Sr Proteins Using an in Vitro Randomization and Functional Selection Procedure, We Have Identified Three Novel Classes of Exonic Splicing Enhancers (eses) Recognized by Human Sf2/asf, Srp40, and Srp55, Respectively , 2022 .
[56] Shulin Li,et al. Nonsense surveillance in lymphocytes? , 1998, Immunity.
[57] C. Mathew,et al. Exon 6 skipping in the fanconi anemia C gene associated with a nonsense/missense mutation (775C→T) in exon 5: The first example of a nonsense mutation in one exon causing skipping of another downstream , 1998, Human mutation.
[58] P. Nürnberg,et al. Nearby stop codons in exons of the neurofibromatosis type 1 gene are disparate splice effectors. , 1998, American journal of human genetics.
[59] M. Tohyama,et al. Human Tra2 Proteins Are Sequence-Specific Activators of Pre-mRNA Splicing , 1998, Cell.
[60] R. Desnick,et al. Familial porphyria cutanea tarda: characterization of seven novel uroporphyrinogen decarboxylase mutations and frequency of common hemochromatosis alleles. , 1998, American journal of human genetics.
[61] R. Kauppinen,et al. Three splicing defects, an insertion, and two missense mutations responsible for acute intermittent porphyria , 1998, Human Genetics.
[62] M. Huynen,et al. A pyrimidine-rich exonic splicing suppressor binds multiple RNA splicing factors and inhibits spliceosome assembly. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[63] G M Lenoir,et al. A BRCA1 nonsense mutation causes exon skipping. , 1998, American journal of human genetics.
[64] U. Francke,et al. A single mutation that results in an Asp to His substitution and partial exon skipping in a family with congenital contractural arachnodactyly , 1998, Human Genetics.
[65] H. Lou,et al. Regulation of Alternative Polyadenylation by U1 snRNPs and SRp20 , 1998, Molecular and Cellular Biology.
[66] Y. Seyama,et al. Silent nucleotide substitution in the sterol 27-hydroxylase gene (CYP 27) leads to alternative pre-mRNA splicing by activating a cryptic 5' splice site at the mutant codon in cerebrotendinous xanthomatosis patients. , 1998, Biochemistry.
[67] J. McPherson,et al. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. , 1999, Human molecular genetics.
[68] In vivo SELEX in vertebrate cells. , 1999, Methods in molecular biology.
[69] D. Helfman,et al. Binding of hnRNP H to an exonic splicing silencer is involved in the regulation of alternative splicing of the rat beta-tropomyosin gene. , 1999, Genes & development.
[70] E. Lander,et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes , 1999, Nature Genetics.
[71] G. Isshiki,et al. Molecular characterization of 6-pyruvoyl-tetrahydropterin synthase deficiency in Japanese patients , 1999, Journal of Human Genetics.
[72] T. Maniatis,et al. Multiple Distinct Splicing Enhancers in the Protein-Coding Sequences of a Constitutively Spliced Pre-mRNA , 1999, Molecular and Cellular Biology.
[73] G. Varani,et al. Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[74] Sara G. Becker-Catania,et al. Splicing defects in the ataxia-telangiectasia gene, ATM: underlying mutations and consequences. , 1999, American journal of human genetics.
[75] M. Green,et al. Pre-mRNA splicing of IgM exons M1 and M2 is directed by a juxtaposed splicing enhancer and inhibitor. , 1999, Genes & development.
[76] Ruggero Montesano,et al. IARC p53 mutation database: A relational database to compile and analyze p53 mutations in human tumors and cell lines , 1999, Human mutation.
[77] Francisco E. Baralle,et al. Regulation of Fibronectin EDA Exon Alternative Splicing: Possible Role of RNA Secondary Structure for Enhancer Display , 1999, Molecular and Cellular Biology.
[78] C. Lorson,et al. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[79] G. Schellenberg,et al. Missense and silent tau gene mutations cause frontotemporal dementia with parkinsonism-chromosome 17 type, by affecting multiple alternative RNA splicing regulatory elements. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[80] D. Pintel,et al. A Premature Termination Codon in Either Exon of Minute Virus of Mice P4 Promoter-generated Pre-mRNA Can Inhibit Nuclear Splicing of the Intervening Intron in an Open Reading Frame-dependent Manner* , 1999, The Journal of Biological Chemistry.
[81] A. Ballabio,et al. Double heterozygosity for a RET substitution interfering with splicing and an EDNRB missense mutation in Hirschsprung disease. , 1999, American journal of human genetics.
[82] M. Olive,et al. hnRNP A1 Recruited to an Exon In Vivo Can Function as an Exon Splicing Silencer , 1999, Molecular and Cellular Biology.
[83] K. Izuhara,et al. A G to A transition at the last nucleotide of exon 6 of the γc gene (868G→A) may result in either a splice or missense mutation in patients with X-linked severe combined immunodeficiency , 1999, Human Genetics.
[84] M. Reid,et al. Molecular basis for Rhnull syndrome: Identification of three new missense mutations in the Rh50 glycoprotein gene , 1999, American journal of hematology.
[85] D. Pintel,et al. A Premature Termination Codon Interferes with the Nuclear Function of an Exon Splicing Enhancer in an Open Reading Frame-Dependent Manner , 1999, Molecular and Cellular Biology.
[86] B. Grandchamp,et al. Characterization of the 415G>A (E139K) PMM2 mutation in carbohydrate‐deficient glycoprotein syndrome type Ia disrupting a splicing enhancer resulting in exon 5 skipping , 1999, Human mutation.
[87] M. Blanchette,et al. Modulation of exon skipping by high‐affinity hnRNP A1‐binding sites and by intron elements that repress splice site utilization , 1999, The EMBO journal.
[88] T. Tabira,et al. FTDP‐17 mutations N279K and S305N in tau produce increased splicing of exon 10 , 1999, FEBS letters.
[89] A. Brookes. The essence of SNPs. , 1999, Gene.
[90] G. Mangiarotti. Coupling of transcription and translation in Dictyostelium discoideum nuclei. , 1999, Biochemistry.
[91] M. Hentze,et al. A Perfect Message RNA Surveillance and Nonsense-Mediated Decay , 1999, Cell.
[92] A. de la Chapelle,et al. Missense and nonsense mutations in codon 659 of MLH1 cause aberrant splicing of messenger RNA in HNPCC kindreds , 1999, Genes, chromosomes & cancer.
[93] Tom Maniatis,et al. Selection and Characterization of Pre-mRNA Splicing Enhancers: Identification of Novel SR Protein-Specific Enhancer Sequences , 1999, Molecular and Cellular Biology.
[94] M. Swanson,et al. hnRNP complexes: composition, structure, and function. , 1999, Current opinion in cell biology.
[95] J. Stévenin,et al. The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers. , 1999, RNA.
[96] Michael Q. Zhang,et al. Exonic Splicing Enhancer Motif Recognized by Human SC35 under Splicing Conditions , 2000, Molecular and Cellular Biology.
[97] K. Hsiao,et al. A silent mutation induces exon skipping in the phenylalanine hydroxylase gene in phenylketonuria , 2000, Human Genetics.
[98] C. Lorson,et al. An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. , 2000, Human molecular genetics.
[99] P. Nürnberg,et al. Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP-related domain. , 2000, American journal of human genetics.
[100] L. Chasin,et al. Multiple Splicing Defects in an Intronic False Exon , 2000, Molecular and Cellular Biology.
[101] Stephen M. Mount,et al. The genome sequence of Drosophila melanogaster. , 2000, Science.
[102] H. Le Hir,et al. The spliceosome deposits multiple proteins 20–24 nucleotides upstream of mRNA exon–exon junctions , 2000, The EMBO journal.
[103] J. Valcárcel,et al. Alternative pre-mRNA splicing: the logic of combinatorial control. , 2000, Trends in biochemical sciences.
[104] N. Sonenberg,et al. Translational control of gene expression , 2000 .
[105] H. Akashi,et al. A test of translational selection at 'silent' sites in the human genome: base composition comparisons in alternatively spliced genes. , 2000, Gene.
[106] R. Perkins,et al. Predicted changes in pre-mRNA secondary structure vary in their association with exon skipping for mutations in exons 2, 4, and 8 of the Hprt gene and exon 51 of the fibrillin gene. , 2000, Mutation research.
[107] A. Krainer,et al. Pre-mRNA splicing in the absence of an SR protein RS domain. , 2000, Genes & development.
[108] J. Vockley,et al. Exon skipping in IVD RNA processing in isovaleric acidemia caused by point mutations in the coding region of the IVD gene. , 2000, American journal of human genetics.
[109] B. Blencowe. Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. , 2000, Trends in biochemical sciences.
[110] B. Graveley. Sorting out the complexity of SR protein functions. , 2000, RNA.
[111] S. Stamm,et al. Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[112] G. Schellenberg,et al. Determinants of 4-Repeat Tau Expression , 2000, The Journal of Biological Chemistry.
[113] Bernhard Hemmer,et al. A point mutation in PTPRC is associated with the development of multiple sclerosis , 2000, Nature Genetics.
[114] N. Sonenberg,et al. Nuclear Eukaryotic Initiation Factor 4e (Eif4e) Colocalizes with Splicing Factors in Speckles , 2000, The Journal of cell biology.
[115] S. Agrawal,et al. Antisense oligonucleotides as modulators of pre-mRNA splicing. , 2000, Methods in molecular biology.
[116] W. Rossoll,et al. The role of SMN in spinal muscular atrophy , 2000, Journal of Neurology.
[117] X. Estivill,et al. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. , 2000, Human molecular genetics.
[118] J. C. Clemens,et al. Drosophila Dscam Is an Axon Guidance Receptor Exhibiting Extraordinary Molecular Diversity , 2000, Cell.
[119] J. T. Dunnen,et al. Dystrophin nonsense mutation induces different levels of exon 29 skipping and leads to variable phenotypes within one BMD family , 2000, European Journal of Human Genetics.
[120] L. Chasin,et al. Human Genomic Sequences That Inhibit Splicing , 2000, Molecular and Cellular Biology.
[121] S. Chew,et al. An exonic splicing silencer in the testes-specific DNA ligase III β exon , 2000 .
[122] International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome , 2001, Nature.
[123] V. Gismondi,et al. A silent mutation in exon 14 of theAPC gene is associated with exon skipping in a FAP family , 2001, Journal of medical genetics.
[124] M. Tzetis,et al. Qualitative and quantitative analysis of mRNA associated with four putative splicing mutations (621+3A→G, 2751+2T→A, 296+1G→C, 1717–9T→C-D565G) and one nonsense mutation (E822X) in the CFTR gene , 2001, Human Genetics.
[125] M. Daly,et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms , 2001, Nature.
[126] J. Mendell,et al. When the Message Goes Awry Disease-Producing Mutations that Influence mRNA Content and Performance , 2001, Cell.
[127] B. Graveley. Alternative splicing: increasing diversity in the proteomic world. , 2001, Trends in genetics : TIG.
[128] D. Jackson,et al. Coupled Transcription and Translation Within Nuclei of Mammalian Cells , 2001, Science.
[129] A. Bindereif,et al. In vitro selection of exonic splicing enhancer sequences: identification of novel CD44 enhancers. , 2001, Nucleic acids research.
[130] C. Will,et al. Spliceosomal UsnRNP biogenesis, structure and function. , 2001, Current opinion in cell biology.
[131] A. Krainer,et al. Pre-mRNA splicing in the new millennium. , 2001, Current opinion in cell biology.
[132] M. Moore,et al. Precursor RNAs harboring nonsense codons accumulate near the site of transcription. , 2001, Molecular cell.
[133] A. Krainer,et al. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins. , 2001, Molecular cell.
[134] Y. Jong,et al. Treatment of spinal muscular atrophy by sodium butyrate , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[135] E. Oláh,et al. Purifying selection on silent sites -- a constraint from splicing regulation? , 2001, Trends in genetics : TIG.
[136] C. Pál,et al. Evidence for purifying selection acting on silent sites in BRCA1. , 2001, Trends in genetics : TIG.
[137] J. Trojanowski,et al. Neurodegenerative tauopathies. , 2001, Annual review of neuroscience.
[138] S. Brogna. Pre-mRNA processing: Insights from nonsense , 2001, Current Biology.
[139] Michael Q. Zhang,et al. A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes , 2001, Nature Genetics.
[140] Massimo Marconi,et al. Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[141] The role of U2AF35 and U2AF65 in enhancer-dependent splicing. , 2001, RNA.
[142] M. Williams,et al. Site and type of mutations in the factor VIII gene in patients and carriers of haemophilia A , 2001, Haemophilia : the official journal of the World Federation of Hemophilia.
[143] E. Wagner,et al. Polypyrimidine Tract Binding Protein Antagonizes Exon Definition , 2001, Molecular and Cellular Biology.
[144] Sharlene R. Lim,et al. Modulation of Survival Motor Neuron Pre-mRNA Splicing by Inhibition of Alternative 3′ Splice Site Pairing* , 2001, The Journal of Biological Chemistry.
[145] L. Maquat,et al. Evidence for a Pioneer Round of mRNA Translation mRNAs Subject to Nonsense-Mediated Decay in Mammalian Cells Are Bound by CBP80 and CBP20 , 2001, Cell.
[146] H. Levy,et al. A missense mutation (Q279R) in the Fumarylacetoacetate Hydrolase gene, responsible for hereditary tyrosinemia, acts as a splicing mutation , 2001, BMC Genetics.
[147] C. Lorson,et al. An in vivo reporter system for measuring increased inclusion of exon 7 in SMN2 mRNA: potential therapy of SMA , 2001, Gene Therapy.
[148] E. Androphy,et al. Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients. , 2001, Human molecular genetics.
[149] O. Hellwinkel,et al. A unique exonic splicing mutation in the human androgen receptor gene indicates a physiologic relevance of regular androgen receptor transcript variants. , 2001, The Journal of clinical endocrinology and metabolism.
[150] J. V. Moran,et al. Initial sequencing and analysis of the human genome. , 2001, Nature.
[151] Christopher J. Lee,et al. A genomic view of alternative splicing , 2002, Nature Genetics.
[152] A. Krainer,et al. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1 , 2002, Nature Genetics.
[153] D. Cooper,et al. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences , 1992, Human Genetics.
[154] B. Poll-The,et al. Hereditary tyrosinemia type 1: novel missense, nonsense and splice consensus mutations in the human fumarylacetoacetate hydrolase gene; variability of the genotype-phenotype relationship , 2004, Human Genetics.